Skip to main content
OpenTrials

Clinical trial condition

Triple-negative Breast Cancer

Explore clinical trials studying Triple-negative Breast Cancer. Study availability and eligibility vary by location and protocol.

78 public trials 30 recruiting studies
Refine in advanced search Browse all conditions

Triple-negative Breast Cancer trial results

Recruiting

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

NCT06393374

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • Infirmary Cancer Care ( Site 0001) Mobile, Alabama, United States
  • Ironwood Cancer & Research Centers-Research ( Site 0054) Chandler, Arizona, United States
  • MemorialCare Orange Coast Medical Center ( Site 9501) Fountain Valley, California, United States
  • Scripps Cancer Center ( Site 0052) La Jolla, California, United States
View all 306 locations
View Trial Details
Recruiting

Pembrolizumab and Chemotherapy Treatment or no Treatment Guided by the Level of TILs in Resected Early-stage TNBC

NCT06078384

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • CHU Amiens Picardie_Site Sud Amiens, France
  • Institut Sainte Catherine Avignon, France
  • Centre Hospitalier de la Côte Basque Bayonne, France
  • Institut Bergonié Bordeaux, France
View all 44 locations
View Trial Details
Recruiting

START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer

NCT05492682

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +44 more
Locations
  • Krankenhaus Nordwest Frankfurt, Germany
  • National Center for Tumor Diseases Heidelberg, Germany
  • Universitätsklinikum Tübingen Tübingen, Germany
  • Istituto di Candiolo Fondazione del Piemonte per l'oncologia IRCCS Candiolo, Italy
View Trial Details
Recruiting

Intratumoral INT230-6 Followed by Neoadjuvant Immuno-chemotherapy in Patients With Early TNBC. INVINCIBLE-4-SAKK

NCT06358573

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +6 more
Locations
  • Tumor Zentrum Aarau Aarau, Switzerland
  • St. Claraspital Basel, Switzerland
  • EOC - IOSI Ospedale regionale Bellinzona e valli - San Giovanni Bellinzona, Switzerland
  • Kantonsspital Graubünden Chur, Switzerland
View Trial Details
Recruiting

Prospective Biobanking Study in Cancer Patients Aiming at Better Understand the Link Between the Molecular Alterations of the Tumor Itself, Its Microenvironment and Immune Response (SCANDARE)

NCT03017573

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +32 more
Locations
  • Institut Bergonie Bordeaux, France
  • Centre Oscar Lambret Lille, France
  • Centre Leon Berard Lyon, France
  • Institut Curie Paris, France
View Trial Details

Related conditions